Comparison of quinazoline and benzoylpyrazoline chemotypes targeting the CaVα-β interaction as antagonists of the N-type CaV2.2 channel

References

• Dolphin AC. Calcium channel diversity: multiple roles of calcium channel subunits. CurrOpinNeurobiol. 2009;19:237–244.
   Google Scholar
• Richards MW, Butcher AJ, Dolphin AC. Ca2+ channel beta-subunits: structural insights AID our understanding. Trends Pharmacol Sci. 2004;25:626–632.
   PubMed Web of Science ®Google Scholar
• Lee S. Pharmacological inhibition of voltage-gated Ca(2+) channels for chronic pain relief. Curr Neuropharmacol. 2013;11:606–620.
   PubMed Web of Science ®Google Scholar
• Safavi-Hemami H, Brogan SE, Olivera BM. Pain therapeutics from cone snail venoms: from Ziconotide to novel non-opioid pathways. J Proteomics. 2019 Jan 6;190:12-20..
   Web of Science ®Google Scholar
• Abbadie C, McManus OB, Sun SY, et al. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker. JPharmacolExpTher. 2010;334:545–555.
   Web of Science ®Google Scholar
• McGivern JG. Ziconotide: a review of its pharmacology and use in the treatment of pain. Neuropsychiatr Dis Treat. 2007;3:69–85.
   PubMedGoogle Scholar
• Schmidtko A, Lotsch J, Freynhagen R, et al. Ziconotide for treatment of severe chronic pain. Lancet. 2010;375:1569–1577.
   PubMed Web of Science ®Google Scholar
• Rauck RL, Wallace MS, Leong MS, et al. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage. 2006;31:393–406.
   PubMed Web of Science ®Google Scholar
• Dolphin AC. Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond. Nat Rev Neurosci. 2012;13:542–555.
   PubMed Web of Science ®Google Scholar
• Taylor CP, Harris EW. Analgesia with gabapentin and pregabalin may involve NMDA receptors, neurexins and thrombospondins. J Pharmacol Exp Ther. 2020 Jul;374(1):161-174.
   Web of Science ®Google Scholar
• Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305.
   PubMed Web of Science ®Google Scholar
• Deeks ED. Mirogabalin: first Global Approval. Drugs. 2019;79:463–468.
   PubMed Web of Science ®Google Scholar
• Brittain JM, Duarte DB, Wilson SM, et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2)(+) channel complex. Nat Med. 2011;17:822–829.
   PubMed Web of Science ®Google Scholar
• Feldman P, Khanna R. Challenging the catechism of therapeutics for chronic neuropathic pain: targeting CaV2.2 interactions with CRMP2 peptides. Neurosci Lett. 2013;557(Pt A):27–36.
   PubMedGoogle Scholar
• Wilson SM, Brittain JM, Piekarz AD, et al. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex. Channels (Austin). 2011;5:449–456.
   PubMed Web of Science ®Google Scholar
• Wilson SM, Schmutzler BS, Brittain JM, et al. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides. J Biol Chem. 2012;287:35065–35077.
   PubMed Web of Science ®Google Scholar
• Francois-Moutal L, Wang Y, Moutal A, et al. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. Pain. 2015;156:1247–1264.
   PubMed Web of Science ®Google Scholar
• Dorame A, Shuja Z, Gokhale V, et al. High-throughput chemical screening identifies SGM-45 as a selective inhibitor of N-type voltage-gated (Cav2.2) channels. Society of Neuroscience Annual meeting, 2017, Washington, DC.
   Google Scholar
• Khanna R, Yu J, Yang X, et al. Targeting the CaValpha-CaVbeta interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy. Pain. 2019;160:1644–1661.
   PubMed Web of Science ®Google Scholar
• Young K, Lin S, Sun L, et al. Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. NatBiotechnol. 1998;16:946–950.
   Google Scholar
• Khanna R, Meroueh S. Treatment of neuropathic pain by a small-molecule inhibitor of beta subunits of voltage-gated calcium channel complexes. In: Corporation IURTC . USA; 2011. p. 1–29.
   Google Scholar
• Chen X, Liu D, Zhou D, et al. Small-molecule CaValpha1CaVbeta antagonist suppresses neuronal voltage-gated calcium-channel trafficking. Proc Natl Acad Sci U S A. 2018;115:E10566–E75.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Ikeda H, Kanase Y, et al. Elucidation of the E-amide preference of N-acyl azoles. J Org Chem. 2017;82:11370–11382.
   PubMed Web of Science ®Google Scholar
• Schepetkin IA, Khlebnikov AI, Quinn MT. N-benzoylpyrazoles are novel small-molecule inhibitors of human neutrophil elastase. J Med Chem. 2007;50:4928–4938.
   PubMed Web of Science ®Google Scholar
• Chen YH, Li MH, Zhang Y, et al. Structural basis of the alpha1-beta subunit interaction of voltage-gated Ca2+ channels. Nature. 2004;429:675–680.
   PubMed Web of Science ®Google Scholar
• Van Petegem F, Clark KA, Chatelain FC, et al. Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. Nature. 2004;429:671–675.
   PubMed Web of Science ®Google Scholar
• Li L, Cao XH, Chen SR, et al. Up-regulation of Cavbeta3 subunit in primary sensory neurons increases voltage-activated Ca2+ channel activity and nociceptive input in neuropathic pain. J Biol Chem. 2012;287:6002–6013.
   PubMed Web of Science ®Google Scholar
• Dustrude ET, Moutal A, Yang X, et al. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Proc Natl Acad Sci U S A. 2016;113:E8443–E52.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739–1749.
   PubMed Web of Science ®Google Scholar
• Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27:221–234.
   PubMed Web of Science ®Google Scholar
• Saff EB, Kuijlaars ABJ. Distributing many points on a sphere. Math Intelligencer. 1997;19:5–11.
   Web of Science ®Google Scholar